I’m not surprised at the interest. From a numbers POV it’s quite a prevalent condition. From a healthcare POV it’s a Godawful disease often ending in dialysis which keeps people alive but their quality of life is Godawful!
Maybe I’m full of it, but I reckon PYC would have already had lowball offers from these predatory weasels. I’m sure RH and AT would have batted them away.
Depends if the weasels want to buy a single asset (eg PKD treatment) or the whole pie. But I think that because PYC potentially has a few assets for sale the price would be high.
PYC Price at posting:
$1.20 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)